Proliferative vitreoretinopathy (PVR) is the most common cause of ultimate failure of retinal reattachment surgery. Specific prophylaxis and treatment are lacking largely because the pathogenesis of PVR is poorly understood. There is good evidence to suggest that cell de- differentiation migration, and proliferation are important processes, however, the nature and origin of the stimuli for these processes are unknown. This proposal is aimed at identifying the stimuli for these processes and the manner by which they gain access to the vitreous cavity. Studies will be performed in human RPE and retinal glia in vitro and in rabbit models of PVR in vivo. Cellular differentiation will be assessed by ultrastructural criteria and intermediate filament expression detected by immunohistochemistry. Cellular migration will be assessed by Boyden chamber assays in vitro and by sequential morphologic analysis in vivo. Cellular proliferation will be assessed by [3H] thymidine incorporation, growth curves, and ornithine decarboxylase activity in vitro and by [3H] thymidine incorporation in vivo. Agents that will be examined include those that have been demonstrated to affect cellular differentiation, including phorbol esters, retinoids, and cyclic AMP as well as several different growth factors. Several agents will also be examined for their ability to inhibit the above cellular processes as well as the development of traction retinal detachment formation in animal models. Investigations concerning access of stimulatory agents to the vitreous will focus on the blood-retinal barrier, cell-derived agents (inflammatory and non-inflammatory) and retina-derived agents. The role of the blood-retinal barrier breakdown will be examined by vitreous flourophotometry and tracer studies. Other studies will investigate pharmacologic and cell-mediated modulation of the barrier. The contribution of cell-derived agents will focus on modulation of platelet- derived growth factor-like proteins produced by RPE in culture and the role of inflammation in animal models of PVR. The potential role of retina-derived agents will be examined by immunoblots of subretinal fluid obtained from retinal detachment patients. In this manner, we hop to gain a more detailed picture of the pathogenic mechanisms involved in PVR so that strategies to prevent and interrupt them can be designed.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
2R01EY005951-05
Application #
3261703
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1985-09-30
Project End
1994-09-29
Budget Start
1989-09-30
Budget End
1990-09-29
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Shen, Jikui; Choy, David F; Yoshida, Tsunehiko et al. (2014) Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGF. J Cell Physiol 229:974-83
Ohnaka, Masayuki; Miki, Katsuaki; Gong, Yuan-Yuan et al. (2012) Long-term expression of glial cell line-derived neurotrophic factor slows, but does not stop retinal degeneration in a model of retinitis pigmentosa. J Neurochem 122:1047-53
Usui, Shinichi; Oveson, Brian C; Iwase, Takeshi et al. (2011) Overexpression of SOD in retina: need for increase in H2O2-detoxifying enzyme in same cellular compartment. Free Radic Biol Med 51:1347-54
Oveson, Brian C; Iwase, Takeshi; Hackett, Sean F et al. (2011) Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration. J Neurochem 116:144-53
Dong, Aling; Xie, Bing; Shen, Jikui et al. (2009) Oxidative stress promotes ocular neovascularization. J Cell Physiol 219:544-52
Lu, Lili; Oveson, Brain C; Jo, Young-Joon et al. (2009) Increased expression of glutathione peroxidase 4 strongly protects retina from oxidative damage. Antioxid Redox Signal 11:715-24
Usui, Shinichi; Oveson, Brian C; Lee, Sun Young et al. (2009) NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa. J Neurochem 110:1028-37
Usui, Shinichi; Komeima, Keiichi; Lee, Sun Young et al. (2009) Increased expression of catalase and superoxide dismutase 2 reduces cone cell death in retinitis pigmentosa. Mol Ther 17:778-86
Komeima, Keiichi; Usui, Shinichi; Shen, Jikui et al. (2008) Blockade of neuronal nitric oxide synthase reduces cone cell death in a model of retinitis pigmentosa. Free Radic Biol Med 45:905-12
Chowers, Itay; Wong, Robert; Dentchev, Tzvete et al. (2006) The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration. Invest Ophthalmol Vis Sci 47:2135-40